ライフサイエンスコーパス: endobronchial

1 ermined by computerized tomography (CT), and endobronchial abnormalities at bronchoscopy; (2) number,

2 Using a murine model, we demonstrated that endobronchial administration of antibodies (Abs) to majo

3 choalveolar space and change in FEV(1) after endobronchial allergen challenge (EBAC) in atopic asthma

4 e regional allergic reaction after segmental endobronchial allergen challenge.

5 ne challenge, inhaled allergen challenge and endobronchial allergen provocation through a bronchoscop

6 choline and inhaled allergen challenges, and endobronchial allergen provocations through a bronchosco

7 went two bronchoscopies with proximal airway endobronchial and distal alveolar tissue transbronchial

8 went two bronchoscopies with proximal airway endobronchial and distal alveolar tissue transbronchial

9 Endobronchial and transbronchial biopsies were performed

10 Similar results were obtained in the endobronchial and transbronchial biopsy specimens, which

11 Sections of concurrently obtained endobronchial and transbronchial/surgical biopsy tissue

12 transplantation, usually in association with endobronchial bacterial infection.

13 0 days after transplantation (n = 11) and/or endobronchial biopsies (n = 14) at 30 days for real-time

14 amined in blood, bronchoalveolar lavage, and endobronchial biopsies 48 hours after challenge.

15 the change in ASM transcriptomic profile in endobronchial biopsies after 14 days of oral glucocortic

16 expression of the protein phosphatase PP5 in endobronchial biopsies and ASM cells.

17 performed 6 h after each exposure to obtain endobronchial biopsies and bronchial wash (BW) cells.

18 Endobronchial biopsies and bronchoalveolar lavage fluid

19 protein-protein interactions are observed in endobronchial biopsies and fresh epithelial cells from a

20 We evaluated lymphocytic bronchitis on endobronchial biopsies as a risk factor for BOS and mort

21 compared the ASM transcriptomic profiles of endobronchial biopsies between glucocorticoid-free, atop

22 e chain reaction and immunohistochemistry in endobronchial biopsies from 13 subjects with mild and mo

23 hree different collagen staining methods, in endobronchial biopsies from 17 severe, nine moderate, an

24 y and quantitative real-time PCR analysis of endobronchial biopsies from 27 mild-to-moderate asthmati

25 tion of the bronchial epithelium observed in endobronchial biopsies from asthmatic subjects is a true

26 e that denudation of bronchial epithelium in endobronchial biopsies from asthmatic subjects with stab

27 eta2, and mucin expression were evaluated in endobronchial biopsies from asthmatics and normal subjec

28 We compared ASM cultured from endobronchial biopsies from subjects with and without as

29 Immunohistochemical staining of endobronchial biopsies identified epithelial localizatio

30 ion was also increased in the ASM bundles in endobronchial biopsies in severe asthmatics.

31 lls were determined in ultrathin sections of endobronchial biopsies obtained from 53 infants during c

32 gene expression profile of the ASM layer in endobronchial biopsies of patients with asthma is altere

33 Immunohistochemical staining of endobronchial biopsies revealed that KCa3.1 channels are

34 Immunohistochemical analyses of endobronchial biopsies showed a remarkable loss of caveo

35 Endobronchial biopsies were collected and graded during

36 an respiratory epithelial cells derived from endobronchial biopsies were cultured using a combination

37 Endobronchial biopsies were performed at the end of 12 w

38 dilation (DeltaR(rs) ) and bronchoscopy with endobronchial biopsies were performed.

39 Endobronchial biopsies were taken before and after 14 da

40 e, respectively), as well as mucosal tissue (endobronchial biopsies).

41 gene expression, quantitative morphometry of endobronchial biopsies, and levels of secreted protein.

42 r each exposure to obtain airway lavages and endobronchial biopsies.

43 vere asthma (N-SA; n = 8) were cultured from endobronchial biopsies.

44 pression in bronchoalveolar lavage cells and endobronchial biopsies.

45 challenge, and fiberoptic bronchoscopy with endobronchial biopsy (always right upper lobe second-gen

46 IL-33 expression was quantified in endobronchial biopsy (EB) specimens from children with S

47 induction, bronchoalveolar lavage (BAL) and endobronchial biopsy (EB).

48 e of macrophages/DC in lung allografts using endobronchial biopsy (EBB) and transbronchial biopsy (TB

49 ant diisocyanate-conjugated protein in human endobronchial biopsy samples, whereas albumin was the pr

50 ed and quantified by immunohistochemistry in endobronchial biopsy sections from smoking and non-smoki

51 We sought to determine endobronchial biopsy specimen ASM area fraction in presc

52 hiolitis defined by pathological criteria on endobronchial biopsy specimens (in heart-lung/lung patie

53 Endobronchial biopsy specimens from allergen-challenged

54 lly differentiated bronchial epithelium from endobronchial biopsy specimens maintain inherent phenoty

55 Primary human fibroblasts were cultured from endobronchial biopsy specimens obtained from healthy or

56 nflammatory imbalances initially observed in endobronchial biopsy specimens obtained from patients wi

57 ultures of bronchial epithelium derived from endobronchial biopsy specimens of patients with differen

58 uman bronchial epithelial cells derived from endobronchial biopsy specimens of patients with mild and

59 and ASM mast cell values were quantified in endobronchial biopsy specimens previously obtained from

60 oduction, were assessed in paraffin-embedded endobronchial biopsy specimens to evaluate morphologic c

61 e density of FABP4-immunoreactive vessels in endobronchial biopsy specimens was significantly higher

62 Endobronchial biopsy specimens, epithelial brushings, an

63 inophils, followed by bronchoscopy, BAL, and endobronchial biopsy within 24 h.

64 nological sampling of blood, induced sputum, endobronchial biopsy, and bronchoalveolar lavage for flo

65 ical assessment and provided induced sputum, endobronchial biopsy, bronchoalveolar lavage, and blood

66 CS-dependent asthmatics were evaluated with endobronchial biopsy, pulmonary function, allergy testin

67 epithelial and endothelial cells obtained by endobronchial biopsy.

68 putum induction, bronchoalveolar lavage, and endobronchial biopsy.

69 nchoscopy, bronchoalveolar lavage (BAL), and endobronchial biopsy.

70 An endobronchial blocker was placed into the left main stem

71 ous positive airway pressure applied via the endobronchial blocker.

72 ion therapy were treated with palliative HDR endobronchial brachytherapy for symptoms due to relapse

73 HDR endobronchial brachytherapy is an effective method to re

74 had minimal symptomatic improvement with HDR endobronchial brachytherapy.

75 mptoms due to relapse or persistent tumor of endobronchial bronchogenic origin.

76 ere obtained by BAL, and BE were obtained by endobronchial brush biopsy from 15 grain handlers 6 h af

77 ed tomography-guided transthoracic biopsy or endobronchial brushing for undiagnosed nodules.

78 s (5 signatures), sputum (3 signatures), and endobronchial brushings (6 signatures).

79 utum (n = 83), nasal brushings (n = 41), and endobronchial brushings (n = 65) and biopsies (n = 47) (

80 Endobronchial brushings and biopsies were obtained and e

81 DNA was extracted from endobronchial brushings and bronchoalveolar lavage fluid

82 in cultured bronchial epithelial cells from endobronchial brushings of both subject groups.

83 bronchoscopy, bronchoalveolar lavage (BAL), endobronchial brushings, and biopsy.

84 10(9) colony-forming units (CFU) GBS via an endobronchial catheter (n = 7).

85 Our findings suggest that treatment with endobronchial coils can improve quality of life for pati

86 rinflation treated for 12 months, the use of endobronchial coils compared with usual care resulted in

87 inary clinical trials have demonstrated that endobronchial coils compress emphysematous lung tissue a

88 Endobronchial coils might have a role in the treatment o

89 While accepting that chronic endobronchial colonization with atypical mycobacteria ma

90 g the prostacyclin analogue iloprost reduces endobronchial dysplasia, a premalignant lung lesion.

91 Endobronchial endotoxin was followed by progressive alve

92 immediately extravascular by using primarily endobronchial forceps for caval fragments and snares for

93 The endobronchial forceps technique can be safely used to re

94 The endobronchial forceps technique was used to successfully

95 then removed through the sheath by using the endobronchial forceps.

96 al antibodies, variable bacterial clearance, endobronchial infection and microbial adaptation with PA

97 f the inflammatory response to P. aeruginosa endobronchial infection and that further investigation i

98 Pseudomonas aeruginosa endobronchial infection causes significant morbidity and

99 Chronic endobronchial infection frequently caused by gram-negati

100 and systemic morbidity in mice with chronic endobronchial infection with P. aeruginosa embedded in a

101 ized by abnormal airways secretions, chronic endobronchial infection, and progressive airway obstruct

102 urine model of mucoid Pseudomonas aeruginosa endobronchial infection.

103 sociated with chronic Pseudomonas aeruginosa endobronchial infection.

104 using an animal model of chronic Pseudomonas endobronchial infection.

105 eudomonas aeruginosa strains causing chronic endobronchial infections in cystic fibrosis is their con

106 known as mucoidy, is associated with chronic endobronchial infections in cystic fibrosis.

107 roup was probably associated with accidental endobronchial intubation following tube movement.

108 opious secretions and in cases of accidental endobronchial intubation.

109 c intubation, aspiration, dental injury, and endobronchial intubation.

110 on Wegener's-related subglottic stenosis and endobronchial involvement, it has also become apparent t

111 Analysis of cytokine protein levels in endobronchial lavage (EBL) fluid demonstrated that only

112 The missed tumors manifested as endobronchial lesion (n = 10), solitary parenchymal nodu

113 = 5), pleural effusion (n = 4), and solitary endobronchial lesion (n = 2).

114 ruction promptly for patients with recurrent endobronchial lesions and may be considered as a boost f

115 owever, LC risk in patients with preinvasive endobronchial lesions is unclear.

116 hese results show that proteomic analysis of endobronchial lesions may facilitate the diagnosis of lu

117 Endobronchial location and lower lobe predominance were

118 we evaluated whether eosinophils within the endobronchial lumen can function in vivo as antigen-pres

119 Either bronchoscopy with transbronchial and endobronchial lung biopsies or endosonography (esophagea

120 Endobronchial lymphocytic bronchitis was more prevalent

121 The association of endobronchial lymphocytic inflammation and BOS may have

122 The LLL was subsequently collapsed by endobronchial occlusion following 10 min of 100% O2.

123 e safely or effectively delivered, including endobronchial procedures using flexible or rigid broncho

124 ad severe alveolar inflammation and probable endobronchial sarcoidosis.

125 rs that control this homing pattern, we used endobronchial segmental allergen challenge in human atop

126 n CF, which typically remain confined to the endobronchial spaces, B. cenocepacia can traverse airway

127 10(9) plaque-forming units over 9 months by endobronchial spray to 7 pairs of individuals with CF.

128 m the lower airways of children with chronic endobronchial suppuration.

129 Endobronchial tamponade should only be used as a tempora

130 Preparation for other interventions (endobronchial tamponade, BAE, or surgery in eligible can

131 these polymorphisms were also compared with endobronchial tissue inflammatory cells and local IgE.

132 who underwent lung transplantation underwent endobronchial tissue oximetry of native and donor bronch

133 Compared with native endobronchial tissues, donor tissue oxygen saturations (

134 Intubation with a 37-Fr double-lumen endobronchial tube and ventilation with two oscillatory

135 e a primary xenograft model of SCLC in which endobronchial tumor specimens obtained from chemo-naive

136 Endobronchial ulstrasound-guided core biopsies of the lu

137 ng biopsies or endosonography (esophageal or endobronchial ultrasonography) with aspiration of intrat

138 e lung cancer staging has evolved to include endobronchial ultrasonography-guided transbronchial need

139 Endobronchial ultrasonography-guided transbronchial need

140 ures and lymph nodes, is clearly imaged with endobronchial ultrasonography; (3) a greater short-axis

141 he diagnostic yield was 63.7% when no radial endobronchial ultrasound (r-EBUS) and no EMN were used,

142 Transbronchial needle aspiration guided by endobronchial ultrasound should be considered as the ini

143 The Endobronchial Ultrasound Skills and Tasks Assessment Too

144 mine whether the next step should be biopsy (endobronchial ultrasound-guided biopsy or mediastinoscop

145 N2 or N3 (prN2/3) malignant nodal disease on endobronchial ultrasound-guided transbronchial needle as

146 We aimed to assess endobronchial ultrasound-guided transbronchial needle as

147 centres and randomly assigned them to either endobronchial ultrasound-guided transbronchial needle as

148 on on yield, complications, and tolerance of endobronchial ultrasound-guided transbronchial needle as

149 Real-time endobronchial ultrasound-guided transbronchial needle as

150 The role of endobronchial ultrasound-guided transbronchial needle as

151 Endobronchial ultrasound-guided transbronchial needle as

152 Endobronchial ultrasound-guided transbronchial needle as

153 Endobronchial ultrasound-guided transbronchial needle as

154 r randomized controlled trials of the Zephyr endobronchial valve (EBV) treatment have demonstrated be

155 ilot study of unilateral volume reduction by endobronchial valve insertion.

156 subjects with severe emphysema who underwent endobronchial valve LVR were analyzed retrospectively us

157 Endobronchial valve placement can improve lung volumes a

158 Endobronchial valve placement improves pulmonary functio

159 We compared the safety and efficacy of endobronchial-valve therapy in patients with heterogeneo

160 e of collateral ventilation to bronchoscopic endobronchial-valve treatment (EBV group) or to continue

161 Endobronchial-valve treatment for advanced heterogeneous

162 Endobronchial-valve treatment significantly improved pul

163 ause lobar segments were inaccessible to the endobronchial valves (3 patients).

164 ients, 220 were randomly assigned to receive endobronchial valves (EBV group) and 101 to receive stan

165 Endobronchial valves are designed to exclude the most af

166 For example, the placement of endobronchial valves can substitute for lung reduction s

167 Previous trials with endobronchial valves have yielded modest group benefits

168 Unilateral lobar occlusion with endobronchial valves in patients with heterogeneous emph

169 Insertion of endobronchial valves in selected patients could have ben

170 ung-volume reduction with the use of one-way endobronchial valves is a potential treatment for patien

171 Endobronchial valves that allow air to escape from a pul

172 The most widely used BLVR devices are: endobronchial valves, foam sealant, metallic coils, airw

173 s were cultured from patient sputum (n = 3), endobronchial washings (n = 3), pleural fluid (n = 1), a